期刊
ACS MEDICINAL CHEMISTRY LETTERS
卷 5, 期 1, 页码 23-28出版社
AMER CHEMICAL SOC
DOI: 10.1021/ml400296c
关键词
NMR fragment screening; protein-protein interactions; binding affinity; druggability
资金
- Fundacao para a Ciencia e a Tecnologia (FCT) [SFRH/BD/81735/2011]
- U.K BBSRC [BB/G023123/1]
- European Research Council [ERC-2012-StG-311460 DrugE3CRLs]
- EC [PIEF-GA-2010-275683]
- EMBO ASTF [165-2012]
- BBSRC [BB/G023123/2, BB/G023123/1] Funding Source: UKRI
- Biotechnology and Biological Sciences Research Council [BB/G023123/1, BB/G023123/2] Funding Source: researchfish
- Fundação para a Ciência e a Tecnologia [SFRH/BD/81735/2011] Funding Source: FCT
Modulation of protein-protein interactions (PPIs) with small molecules has been hampered by a lack of lucid methods capable of reliably identifying high-quality hits. In fragment screening, the low ligand efficiencies associated with PPI target sites pose significant challenges to fragment binding detection. Here, we investigate the requirements for ligand-based NMR techniques to detect rule-of-three compliant fragments that form part of known high affinity inhibitors of the PPI between the von Hippel-Lindau protein and the alpha subunit of hypoxia-inducible factor 1 (pVHL:HIF-1 alpha). Careful triaging allowed rescuing weak but specific binding of fragments that would otherwise escape detection at this PPI. Further structural information provided by saturation transfer difference (STD) group epitope mapping, protein-based NMR, competitive isothermal titration calorimetry (ITC), and X-ray crystallography confirmed the binding mode of the rescued fragments. Our findings have important implications for PPI druggability assessment by fragment screening as they reveal an accessible threshold for fragment detection and validation.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据